Imagen de Portada
Código QR

PCa Tx shows significant PFS increase.

Publicado en:Urology Times Vol. 43; no. 5; p. 4
Formato: brief item Journal Article
Publicado: MJH Life Sciences 4/15/2015
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=103131445&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 103131445
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        00939722
        URO
      jtl: Urology Times
      issn: 00939722
      maglogo: N
    pubinfo:
      dt: 4/15/2015
      vid: 43
      iid: 5
      pid: 54670
      pub: MJH Life Sciences
      place: Cranbury, New Jersey
    artinfo:
      ui:
        103131445
        103131445
        109747228
        103131445
      ppf: 4
      ppct: 0
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: PCa Tx shows significant PFS increase.
      aug:
      sug:
        subj:
          Prostatic Neoplasms Therapy
          Survival Analysis
          Treatment Outcomes Evaluation
          Prostate-Specific Antigen
      pubtype: Academic Journal
      doctype:
        brief item
        Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N